Standout Papers
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status (2019)
- Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease (2021)
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease (2019)
- CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts (2018)
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (2020)
Immediate Impact
3 from Science/Nature 116 standout
Citing Papers
The pathogenesis of Parkinson's disease
2024 Standout
Small and long non-coding RNAs: Past, present, and future
2024 Standout
Works of Udo Eichenlaub being referenced
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
2020 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Udo Eichenlaub | 1940 | 1713 | 489 | 565 | 32 | 2.7k | |
| Miriam K. Aronson | 1596 | 1717 | 332 | 504 | 43 | 3.4k | |
| Juan Lantero‐Rodriguez | 1693 | 1371 | 700 | 396 | 52 | 2.7k | |
| Małgorzata Knapik-Czajka | 1416 | 1239 | 400 | 369 | 21 | 2.0k | |
| Sarah E. Monsell | 1704 | 1685 | 389 | 669 | 58 | 3.2k | |
| Matti Vanhanen | 1427 | 1661 | 269 | 643 | 33 | 3.0k | |
| Peder Buchhave | 2085 | 1525 | 620 | 714 | 13 | 2.7k | |
| Keijo Koivisto | 1203 | 1358 | 391 | 490 | 62 | 3.3k | |
| Lena Kilander | 1228 | 1391 | 349 | 539 | 67 | 3.4k | |
| Adam J. Simon | 2012 | 1400 | 813 | 462 | 36 | 3.1k | |
| Andréa Lessa Benedet | 1741 | 1330 | 472 | 490 | 99 | 2.5k |
All Works
Loading papers...